[5 min watch] Second opinion & clinico-pathologic correlation Part 2: Prof Giuseppe Argenziano

skin cancer update

In this second part of a three-part series, Prof Giuseppe Argenziano discusses the way in which a second opinion by an experienced dermatopathologist can significantly improve the clinical management of patients with melanoma. Continue reading “[5 min watch] Second opinion & clinico-pathologic correlation Part 2: Prof Giuseppe Argenziano”

[4 min watch] Second opinion & clinico-pathologic correlation Part 1: Prof Giuseppe Argenziano

skin cancer update

In this first part of a three-part series, Prof Giuseppe Argenziano discusses the way in which a second opinion by an experienced dermatopathologist can significantly improve the clinical management of patients with melanoma. Continue reading “[4 min watch] Second opinion & clinico-pathologic correlation Part 1: Prof Giuseppe Argenziano”

[2 min watch] Top tips for communicating with pathologists

If you see patients with skin cancer concerns, you might spend a lot of time communicating with pathologists to reach a diagnosis for your patients. In this short video, Prof David Wilkinson provides his top tips for effectively communicating with pathologists to achieve faster and more accurate results. Continue reading “[2 min watch] Top tips for communicating with pathologists”

[6 min watch] Skin Cancer Update with Prof Giuseppe Argenziano | April 2021

skin cancer update

In this month’s skin cancer update video with Professor Giuseppe Argenziano, we look at his latest fascinating study into how patient management can change after diagnostic review by a second dermatopathologist.  Continue reading “[6 min watch] Skin Cancer Update with Prof Giuseppe Argenziano | April 2021”

[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [August 2020]

Giuseppe skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano discusses re-excising skin lesions for which the histopathology results are unclear. Using real-life cases, Giuseppe explores what you should do when malignancies recur in sites where previous malignancies were excised, and how to manage these patients. Continue reading “[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [August 2020]”

[3 min read] Dysplastic naevi genetic makeup

dysplastic naevi

This month, I share a useful review article on the often vexed topic of dysplastic naevi. The article summarises new understandings about the genetic makeup of benign and dysplastic naevi, as well as melanoma.

Continue reading “[3 min read] Dysplastic naevi genetic makeup”

[3 min read] What to do when a partial biopsy of a suspected melanoma is performed

partial biopsy

This month, we consider what to do when a partial biopsy of a suspected melanoma is performed.

The general advice is that if a punch or shave (partial) biopsy has been done, then an excision biopsy should be done before a formal wide-local excision. This is so that complete staging (of Breslow thickness) can be assured before the excision is done. Continue reading “[3 min read] What to do when a partial biopsy of a suspected melanoma is performed”

[7 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [March 2019]

Skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about atypical melanocytic lesions: lesions that are histopathologically in between a melanoma and a naevus, with subtle melanoma criteria that are not enough for the pathologist to diagnose the lesion as a melanoma. Continue reading “[7 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [March 2019]”

[3 min read] The problem of dysplastic naevi

dysplastic naevi

We all continue to be plagued by the problem of dysplastic naevi, and especially what to do if we biopsy these lesions and the pathology report comes back with “margins involved”. What should we do? Continue reading “[3 min read] The problem of dysplastic naevi”

[3 min read] Are negative margins in BCC biopsies an accurate predictor of residual disease?

margins

Pathology reports of basal cell carcinoma biopsies often contain comments of positive or negative margins, with only one to two per cent of the margin evaluated. A recent study sought to determine the negative predictive value of basal cell carcinoma biopsy margin status on the absence of residual basal cell carcinoma in the corresponding excision.

Continue reading “[3 min read] Are negative margins in BCC biopsies an accurate predictor of residual disease?”